BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25343488)

  • 21. Preoperative Clinical Characteristics That Identify Potential Low-Volume Transfusion Candidates Among Orthotopic Liver Transplant Patients.
    Blake BS; Aniskevich S; Thomas CS; Ladlie BL
    Exp Clin Transplant; 2016 Aug; 14(4):405-11. PubMed ID: 27506259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictors for continuous renal replacement therapy in liver transplant recipients.
    Kim JM; Jo YY; Na SW; Kim SI; Choi YS; Kim NO; Park JE; Koh SO
    Transplant Proc; 2014; 46(1):184-91. PubMed ID: 24507049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative predictors of short-term mortality in living donor liver transplantation due to acute liver failure.
    Chung HS; Jung DH; Park CS
    Transplant Proc; 2013; 45(1):236-40. PubMed ID: 23375307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor age as a predictor of risk for short-term outcomes after liver transplant.
    Macedo FI; Miranda LE; Fernandes JL; Pádua TC; Figueroa JN; Neto OL; Lacerda CM
    Exp Clin Transplant; 2010 Sep; 8(3):202-9. PubMed ID: 20716037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey.
    Yamashiki N; Sugawara Y; Tamura S; Nakayama N; Oketani M; Umeshita K; Uemoto S; Mochida S; Tsubouchi H; Kokudo N
    Liver Transpl; 2012 Sep; 18(9):1069-77. PubMed ID: 22577093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of patient survival following living donor liver transplantation.
    Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):248-53. PubMed ID: 21669566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-recipient age difference and graft survival in living donor kidney transplantation.
    Lee YJ; Chang JH; Choi HN; Jung JY; Kim YS; Chung WK; Park YH; Lee HH
    Transplant Proc; 2012 Jan; 44(1):270-2. PubMed ID: 22310630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A good prognostic predictor for liver transplantation recipients with benign end-stage liver cirrhosis.
    Wei Q; Nemdharry RS; Zhuang RZ; Li J; Ling Q; Wu J; Shen T; Zhou L; Xie HY; Zhang M; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):164-168. PubMed ID: 28381380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to select suitable hepatocellular carcinoma for liver transplantation by preoperative neutrophil-lymphocyte ratio.
    Xiao GQ; Yan L; Yang J
    Hepatogastroenterology; 2014 Oct; 61(135):2077-83. PubMed ID: 25713913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors associated with outcome in liver retransplantation: multicentric study.
    Mattos RO; Linhares MM; Matos D; Adam R; Bismuth H; Castaing D; Konietzko A; Lerut J; Porte RJ; Neville J; Azoulay D
    Hepatogastroenterology; 2015; 62(138):341-5. PubMed ID: 25916060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood transfusion requirement during liver transplantation is an important risk factor for mortality.
    Rana A; Petrowsky H; Hong JC; Agopian VG; Kaldas FM; Farmer D; Yersiz H; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2013 May; 216(5):902-7. PubMed ID: 23478547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of repeat Kasai hepatic portoenterostomy on pediatric live-donor liver graft for biliary atresia.
    Urahashi T; Ihara Y; Sanada Y; Wakiya T; Yamada N; Okada N; Mizuta K
    Exp Clin Transplant; 2013 Jun; 11(3):259-63. PubMed ID: 23530849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.
    Kim JD; Choi JY; Kwon JH; Jang JW; Bae SH; Yoon SK; You YK; Kim DG
    Transplant Proc; 2009 Nov; 41(9):3766-8. PubMed ID: 19917383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.